Tema Cardiovascular and Metabolics ETF (HRTS) Short Interest Ratio & Short Volume

Short interest is the volume of Tema Cardiovascular and Metabolics ETF shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 400 shares of HRTS short. 0.02% of Tema Cardiovascular and Metabolics ETF's shares are currently sold short. Learn More on Tema Cardiovascular and Metabolics ETF's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Tema Cardiovascular and Metabolics ETF's floating shares are currently sold short.

Tema Cardiovascular and Metabolics ETF saw a decrease in short interest in May. As of May 31st, there was short interest totaling 400 shares, a decrease of 86.7% from the previous total of 3,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.02% of Tema Cardiovascular and Metabolics ETF's shares are currently sold short. Here is how the short interest of companies compare to Tema Cardiovascular and Metabolics ETF: Fidelity Disruptive Medicine ETF (0.03%), Tradr 2X Long Innovation ETF (4.24%), AOT Growth & Innovation ETF (0.09%), Siren Nasdaq NexGen Economy ETF (0.21%), Spear Alpha ETF (0.65%), Global X Aging Population ETF (0.05%), Tradr 2X Short Innovation Daily ETF (4.16%), First Trust Dow Jones International Internet ETF (0.18%), Democratic Large Cap Core ETF (0.90%), Global X Genomics & Biotechnology ETF (0.27%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling HRTS is an investing strategy that aims to generate trading profit from Tema Cardiovascular and Metabolics ETF as its price is falling. HRTS shares are trading up $0.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tema Cardiovascular and Metabolics ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HRTS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRTS, twice per month. The most recent reporting period available is May, 31 2025.